Protein Synthesis

Overview

Protein synthesis — encompassing both transcription (DNA to mRNA) and translation (mRNA to protein) — is the process by which cells produce the proteins required for virtually every biological function. From structural components and enzymes to hormones and signaling molecules, proteins are the workhorses of cellular life. The human body synthesizes and degrades approximately 300 grams of protein daily, with rates varying dramatically between tissues and physiological states.

Translation, the ribosomal decoding of mRNA into polypeptide chains, is tightly regulated by nutrient availability, hormonal signals, and growth factor pathways. The mTOR pathway serves as the master integrator of these signals, coordinating translation initiation with the cell's capacity to support new protein production.

How It Works

Transcription (Nuclear Phase)

1. Initiation — RNA polymerase II binds the gene promoter, aided by transcription factors
2. Elongation — RNA polymerase synthesizes pre-mRNA complementary to the template DNA strand
3. Processing — The pre-mRNA undergoes 5' capping, 3' polyadenylation, and splicing to remove introns
4. Export — Mature mRNA is transported through nuclear pores to the cytoplasm

Translation (Ribosomal Phase)

Initiation — The rate-limiting step. The small ribosomal subunit (40S) binds the mRNA 5' cap with the help of eukaryotic initiation factors (eIFs). eIF4E (cap-binding protein) and eIF4G form the eIF4F complex that recruits the ribosome. The 40S subunit scans to the start codon (AUG), where the large subunit (60S) joins to form the active 80S ribosome.

Elongation — Aminoacyl-tRNAs deliver amino acids to the ribosomal A-site based on codon-anticodon pairing. Peptide bonds form between adjacent amino acids, and the ribosome translocates along the mRNA. eEF1A and eEF2 (elongation factors) facilitate these steps.

Termination — When the ribosome encounters a stop codon, release factors trigger polypeptide release. The ribosomal subunits dissociate and are recycled.

Regulation via mTOR

The mTOR pathway controls translation primarily at the initiation step. When mTORC1 is active (nutrients and growth factors present), it phosphorylates 4E-BP1, releasing eIF4E for cap-dependent translation initiation. mTORC1 also activates S6K1, which phosphorylates ribosomal protein S6 and eIF4B, enhancing translation of mRNAs encoding ribosomal proteins and translation factors.

Key Components

• Ribosomes (80S) — The molecular machines that catalyze peptide bond formation
• mRNA — The template encoding the amino acid sequence
• Transfer RNA (tRNA) — Adapter molecules carrying amino acids to the ribosome
• eIF4F complex — The cap-binding complex essential for translation initiation
• mTORC1 — The kinase complex that coordinates translation with nutrient and growth factor status

Peptide Connections

Protein synthesis is regulated by multiple growth factor peptides and signaling pathways:

IGF-1 is one of the most potent activators of protein synthesis. IGF-1 binds its receptor tyrosine kinase, activating the PI3K/Akt pathway, which in turn activates mTORC1. This cascade stimulates translation initiation through 4E-BP1 phosphorylation and S6K1 activation. The growth hormone axis drives IGF-1 production in the liver, linking systemic growth signals to cellular protein synthesis.

Follistatin promotes protein synthesis by inhibiting myostatin and activin, negative regulators of muscle growth. By relieving myostatin's brake on the Akt/mTOR pathway, follistatin shifts the balance toward increased translation and muscle hypertrophy. This mechanism is particularly relevant in muscle protein synthesis.

MGF (mechano-growth factor), a splice variant of IGF-1, is produced locally in response to mechanical loading of muscle tissue. MGF activates satellite cells and stimulates local protein synthesis through mTOR-dependent pathways, contributing to exercise-induced muscle adaptation.

MOTS-c influences protein synthesis indirectly through AMPK activation. AMPK opposes mTORC1 signaling, shifting the balance from translation toward autophagy and energy conservation during metabolic stress. This regulatory axis ensures that protein synthesis only proceeds when cellular energy supplies are adequate.

Insulin stimulates protein synthesis through the PI3K/Akt/mTOR axis, independent of its metabolic effects. Postprandial insulin release, combined with amino acid availability (particularly leucine), creates the optimal conditions for translation initiation.

Clinical Significance

Dysregulated protein synthesis underlies many disease states. In cancer, constitutive activation of mTOR and translation initiation drives uncontrolled proliferation. Rapamycin analogs (rapalogs) that inhibit mTORC1 are used clinically to suppress excessive protein synthesis in certain cancers and in organ transplant rejection.

In sarcopenia (age-related muscle loss), anabolic resistance — a blunted protein synthetic response to feeding and exercise — contributes to progressive muscle wasting. Strategies to overcome anabolic resistance, including optimized protein intake and resistance exercise, target the mTOR-dependent translation machinery.

Related Topics

• mTOR Pathway — Master regulator of translation initiation
• Muscle Protein Synthesis — Tissue-specific protein synthesis in skeletal muscle
• DNA Replication — The upstream process of genome duplication
• Autophagy Process — The opposing catabolic process regulated reciprocally with protein synthesis
• Cell Division — Requires coordinated protein synthesis for daughter cell formation